SR604 for von willebrand diseases

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 26 Nov 2025: Trial started, NCT07640893
  2. 11 Jun 2026: Trial registered, NCT07640893

The trials

NCT07640893: A Phase II Clinical Trial to Evaluate the Efficacy, Safety, and Pharmacokinetics of SR604 Injection in Patients With Von Willebrand Disease

State
Under way
Phase
Phase 2
People
24 planned
Started
26 Nov 2025
Primary completion
31 Dec 2027
Arms
Multiple-dose exploratory efficacy trial consists of 4 cohorts
Results
None posted
  1. 26 Nov 2025: Trial started
  2. 11 Jun 2026: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.